As AAV gene therapy programs advance toward clinical and commercial manufacturing, process development increasingly depends on analytical tools that deliver rapid, actionable insights into vector quality. Realizing the full value of these data requires more than sensitive instrumentation. It requires robust assays supported by high-quality reference materials, standardized reagents, and validated analytical reagents.
In this webinar, Martin Marz (PROGEN) will explore the evolving analytical landscape of AAV manufacturing, review critical quality attributes (CQAs), and discuss the essential role of reference materials and analytical reagents in developing reliable, reproducible assays. Francisco Ramirez (Bio-Techne) will present a high-throughput, multi-attribute automated capillary immunoassay workflow using the Leo™ System, powered by Simple Western™ technology. The workflow enables rapid monitoring of Rep proteins, capsid titer, and empty/full capsid ratios directly from AAV production samples.
Leveraging well-characterized antibodies, recombinant proteins, and AAV reference materials from PROGEN, this integrated solution provides rapid insight into vector production kinetics and product quality. Attendees will learn how multi-attribute analytics and standardized reference materials can support data-driven process optimization, accelerate development timelines, and increase confidence in manufacturing decisions.